These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11084934)

  • 61. High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic.
    Sharma YD; Biswas S; Pillai CR; Ansari MA; Adak T; Devi CU
    Acta Trop; 1996 Dec; 62(3):135-41. PubMed ID: 9025981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
    Kerketta AS; Mohapatra SS; Kar SK
    Trop Doct; 2008 Apr; 38(2):82-4. PubMed ID: 18453492
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spread of artemisinin resistance in malaria.
    Hawkes M; Conroy AL; Kain KC
    N Engl J Med; 2014 Nov; 371(20):1944-5. PubMed ID: 25390755
    [No Abstract]   [Full Text] [Related]  

  • 64. Progress in in silico functional genomics: the malaria Metabolic Pathways database.
    Ginsburg H
    Trends Parasitol; 2006 Jun; 22(6):238-40. PubMed ID: 16707276
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Application of genomics to field investigations of malaria by the international centers of excellence for malaria research.
    Volkman SK; Ndiaye D; Diakite M; Koita OA; Nwakanma D; Daniels RF; Park DJ; Neafsey DE; Muskavitch MA; Krogstad DJ; Sabeti PC; Hartl DL; Wirth DF
    Acta Trop; 2012 Mar; 121(3):324-32. PubMed ID: 22182668
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protein-drug interaction studies for development of drugs against Plasmodium falciparum.
    de Azevedo WF; Caceres RA; Pauli I; Timmers LF; Barcellos GB; Rocha KB; Soares MB
    Curr Drug Targets; 2009 Mar; 10(3):271-8. PubMed ID: 19275563
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In-depth comparative analysis of malaria parasite genomes reveals protein-coding genes linked to human disease in Plasmodium falciparum genome.
    Liu X; Wang Y; Liang J; Wang L; Qin N; Zhao Y; Zhao G
    BMC Genomics; 2018 May; 19(1):312. PubMed ID: 29716542
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular assays for surveillance of antifolate-resistant malaria.
    Kublin JG; Witzig RS; Shankar AH; Zurita JQ; Gilman RH; Guarda JA; Cortese JF; Plowe CV
    Lancet; 1998 May; 351(9116):1629-30. PubMed ID: 9620719
    [No Abstract]   [Full Text] [Related]  

  • 69. Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.
    Myrick A; Leemann E; Dokomajilar C; Hopkins H; Dorsey G; Kamya MR; Rosenthal PJ
    Am J Trop Med Hyg; 2006 May; 74(5):758-61. PubMed ID: 16687676
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antimalarial drug resistance and mortality in falciparum malaria.
    White N
    Trop Med Int Health; 1999 Jul; 4(7):469-70. PubMed ID: 10470336
    [No Abstract]   [Full Text] [Related]  

  • 71. Tracing the geographic origins of Plasmodium falciparum malaria parasites.
    Su XZ
    Pathog Glob Health; 2014 Sep; 108(6):261-2. PubMed ID: 25351581
    [No Abstract]   [Full Text] [Related]  

  • 72. Sequence of Plasmodium falciparum chromosome 12.
    Hyman RW; Fung E; Conway A; Kurdi O; Mao J; Miranda M; Nakao B; Rowley D; Tamaki T; Wang F; Davis RW
    Nature; 2002 Oct; 419(6906):534-7. PubMed ID: 12368869
    [TBL] [Abstract][Full Text] [Related]  

  • 73. K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014.
    Torrentino-Madamet M; Collet L; Lepère JF; Benoit N; Amalvict R; Ménard D; Pradines B
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7878-81. PubMed ID: 26416865
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Volunteer infection studies accelerate the clinical development of novel drugs against malaria.
    Daubenberger C; Burrows JN
    Lancet Infect Dis; 2022 Jun; 22(6):753-754. PubMed ID: 35247323
    [No Abstract]   [Full Text] [Related]  

  • 75. PlasmoDB: An integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data. The Plasmodium Genome Database Collaborative.
    The Plasmodium Genome Database Collaborative
    Nucleic Acids Res; 2001 Jan; 29(1):66-9. PubMed ID: 11125051
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genome-informed contributions to malaria therapies: feeding somewhere down the (pipe)line.
    Waters AP
    Cell Host Microbe; 2008 May; 3(5):280-3. PubMed ID: 18474354
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bioinformatics and the malaria genome: facilitating access and exploitation of sequence information.
    Coppel RL
    Mol Biochem Parasitol; 2001 Dec; 118(2):139-45. PubMed ID: 11738704
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Core promoters are predicted by their distinct physicochemical properties in the genome of Plasmodium falciparum.
    Brick K; Watanabe J; Pizzi E
    Genome Biol; 2008; 9(12):R178. PubMed ID: 19094208
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Malaria vaccines: a test for global health.
    The Lancet
    Lancet; 2024 Feb; 403(10426):503. PubMed ID: 38341240
    [No Abstract]   [Full Text] [Related]  

  • 80. The US-Mexico border, migration crisis, and falciparum malaria.
    Rendón-Hernández AP; Ramírez-González LE; Martínez-Velázquez M; Vázquez-Zamora C; Leal-Escobar B; Soto-Hernández JL
    Lancet Infect Dis; 2023 Dec; 23(12):e507-e508. PubMed ID: 37949092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.